Clinical significance of serum prealbumin in gynecologic malignancy.
- Author:
Mi Suk NAM
1
;
Bok Ja KIM
;
Young Tae KIM
;
Jae Wook KIM
;
Sung Hoon KIM
;
Jong Hwan ROH
Author Information
1. Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Nutritional parameter;
Prealbumin;
Postoperative complication
- MeSH:
Carcinoma in Situ;
Cervix Uteri;
Diagnosis;
Female;
Half-Life;
Humans;
Lymphocyte Count;
Nutritional Status;
Ovarian Neoplasms;
Postoperative Complications;
Prealbumin*;
Prognosis;
Retrospective Studies;
Serum Albumin;
Uterine Cervical Neoplasms;
Uterine Neoplasms
- From:Korean Journal of Obstetrics and Gynecology
2005;48(4):929-937
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The prognosis of gynecologic malignancies was closely related to the nutritional status of patients as well as clinical or surgical staing at the time of diagnosis. The serum prealbumin has relatively short half-life among the nutritional parameters and could be used to detect immediate postoperative change of nutritional state in surgical patients. The purpose of this study was to evaluate the clinical impact of serum prealbumin and the validity of prealbumin in prediction and detection of postoperative complications in high risk patients with gynecologic malignancy. METHODS: 153 gynecologic malignant patients and 68 non-malignant patients operated from January 1999 to May 2003 were studied retrospectively. The serum albumin, total lymphocyte count (TLC), prealbumin were compared between the malignant and non-malignant patients, early and advanced stage cancer group, and complicated and uncomplicated group. Prealbumin was defined as the difference between preoperative and postoperative prealbumin concentrations. The correlation was statistically analyzed by Student's t-test, one way ANOVA test, and x2-test (SPSS ver. 11.0). RESULTS: There was significant difference in prealbumin between non-malignant patients and malignant patients (p=0.049). There was also significant difference in prealbumin between carcinoma in situ of uterine cervix and cervical cancer group (p=0.049). However there were no significant differences in prealbumin between early and advanced stage ovarian cancer and uterine cancer (p=0.48, p=0.67, respectively). There were no significant differneces between complicated and uncomplicated groups in prealbumin and delta prealbumin. CONCLUSION: Serum prealbumin was not useful in prediction and detection of high risk group of postoperative complications in gynecologic cancer patients.
